Trimble Bulls in Control as Options Skew Turns Decisively Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
TRMB has had a strong month, climbing 14% to $65.61, and options traders are now positioned for further gains rather than bracing for a pullback.
The options market tells the clearest story this week. Call demand has outstripped puts sharply, with the put/call ratio dropping to 0.34, more than 1.4 standard deviations below its 20-day mean of 0.39. That is close to the lowest reading of the past year (the 52-week trough is 0.20), pointing to an unusually bullish tilt in the options book. The shift is notable given the stock has already posted its best monthly run in some time. Borrow conditions carry no contradictory signal: availability in the lending market is vast, with roughly 61 times as many shares available to borrow as there are currently on loan, well above the tightest reading of the past year. Cost to borrow has edged up 31% on the week to 0.47%, but that remains trivially low. Short interest at 3.9% of the free float is unremarkable, and it has drifted slightly lower over the past five days. Shorts are not pressing the trade.
The Street broadly agrees that there is more upside ahead, though conviction is not uniform. Ten analysts carry buy ratings against no visible bear camp, and the mean price target of $79 implies roughly 20% further from current levels, a gap that looks credible given the fundamentals. Loop Capital initiated coverage last week with a buy rating and a $76 target, reinforcing the direction of travel. JP Morgan trimmed its target by $1 to $75 in early October while holding its Overweight rating, a minor adjustment rather than a change of view. The bull case rests on durable ARR momentum: Q2 revenue beat consensus by $22 million, ARR reached $2.51 billion growing 12% organically, and full-year guidance was lifted to 8% to 10% organic revenue growth. Barclays and Piper Sandler are both above the consensus at $80 and $87 respectively. The bear case is a valuation one: software multiples have compressed, and even with Trimble's recurring-revenue mix, some analysts have moved to lower terminal FCF multiples, pulling targets down from levels above $85 earlier in the year. The forward P/E has expanded about 1.5 points over the past 30 days to roughly 16x, modest for a software-tilted business, and EV/EBITDA sits near 13x. The 12-month forward EPS growth factor ranks in the 88th percentile, the most striking single factor in the scorecard, while analyst recommendation divergence ranks in the 97th percentile, reflecting an unusually clean consensus skew to the upside.
One institutional footnote worth flagging: Columbia Management filed a 13G in August disclosing a 5.4% stake of roughly 12.7 million shares, and the data shows they added approximately 10.2 million shares in the most recent reported quarter to reach that level. Vanguard and BlackRock remain the largest holders at 7.1% and 6.7% respectively, both with modest additions in Q3. The activist register shows no 13D filer, the ownership picture is entirely passive. On the insider side, activity is thin and unexciting. Director Gabriel Kaigham sold 2,476 shares at $65 on October 29, but it was executed under a pre-arranged 10b5-1 plan, the kind of mechanical disposal that carries no informational weight. The 90-day net is a marginal negative: about 4,200 shares sold at a combined value of $264,000, too small to read as a conviction signal.
Wikipedia page views for Trimble have seen a small uptick in retail attention relative to their own 90-day history, the signal running at a z-score of about 2.0 as of late October. That is a measure of interest, not a revenue indicator, but it aligns with the broader pattern of increasing engagement after the Q2 beat.
The next scheduled earnings event falls on 8 February 2027. Between now and then, the question worth watching is whether the ARR growth rate in AECO and Field Systems sustains the 12% to 14% organic pace the bulls are underwriting, or whether software multiple compression reasserts itself and pulls the stock back toward the lower end of the analyst target range.
Stocks in this article
See the live data behind this article on ORTEX.
Open TRMB on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 18:55
- Data as of
- 4 Nov 2026, 18:47
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.